Thermal expansion of organic crystals and precision of calculated crystal density: A survey of Cambridge crystal database

Journal of Pharmaceutical Sciences

Volumn 96, Issue 5, 2007, Pages 1043-1052

  Sun, Changquan Calvin ^a  

^a AMGEN INC   (United States)

Author keywords

Crystals; Density rule; Polymorphs; Thermal expansion; True density

Indexed keywords

4 NITROANILINE;

ACCURACY; ARTICLE; CRYSTAL STRUCTURE; DATA BASE; DENSITY; TEMPERATURE SENSITIVITY; THERMAL ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 34249079199     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20928     Document Type: Article

References (20)

1. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. II. Applicability of thermodynamic rules. Mikrochim Acta 2:273-316.
2. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules. Mikrochim Acta 2:259-271.
3. Heckel RW. 1961. Density-pressure relations in powder compaction. Trans Metallogr Soc AIME 221:671-675.
4. Kuentz M, Leuenberger H. 1999. Pressure susceptibility of polymer tablets as a critical property: A modified Heckel equation. J Pharm Sci 88:174-179.
5. Sun CC, Grant DJW. 2001. Influence of elastic deformation of particles on Heckel analysis. Pharm Dev Technol 6:193-200.
6. Sun CC. 2005. Quantifying errors in tableting data analysis using the Ryshkewitch equation due to inaccurate true density. J Pharm Sci 94:2061-2068.
7. Sun CC. 2005. Critical roles of porosity in tableting properties characterization and solids formulation development. Am Pharm Rev 8:102, 104-107.
8. Duncan-Hewitt WC, Grant DJW. 1986. True density and thermal expansivity of pharmaceutical solids: Comparison of methods and assessment of crystallinity. Int J Pharm 28:75-84.
9. Saleki-Gerhardt Azita, Ahlneck C, Zografi G. 1994. Assessment of disorder in crystalline solids. Int J Pharm 101:237-247.
10. Sun CC. 2004. A novel method for deriving true density of pharmaceutical solids including hydrates and water-containing powders. J Pharm Sci 93:646-653.
11. Richards FM, Lindley PF. 1999. Determination of the density of solids. In: Wilson AJC, editor. International tables for crystallography, Vol C. Mathematical, Physical and Chemical tables 2nd ed. Dordrecht, The Netherlands: Kluwer Academic Publishers Group, pp 156-159.
12. Herbstein FH. 2000. How precise are measurements of unit-cell dimensions from single crystals? Acta Crystallogr, Sect B: Struct Sci B56:547-557.
13. Allen FH. 2002. The Cambridge structure database: A quarter of a million crystal structures and rising. Acta Cryst B58:380-388.
14. Stephenson GA. 2006. Anisotropic lattice contraction in pharmaceuticals: The influence of cryocrystallography on calculated powder diffraction patterns. J Pharm Sci 95:821-827.
15. Colapietro M, Domenicano A, Marciante, C, Portalone G. 1982. Effects of through-conjugation on the molecular structure of p-nitroaniline. Zeitschrift fuer Naturforschung, Teil B: Anorganische Chemie, Organische Chemi 37B:1309-1311.
16. Tonogaki M, Kawata T, Ohba S, Iwata Y, Shibuya I. 1993. Electron-density distribution in crystals of p-nitrobenzene derivatives. Acta Crystallogr B B49:1031-1039.
17. Trueblood KN, Goldish E, Donohue J. 1961. A three-dimensional refinement of the crystal structure of 4-nitroaniline. Acta Cryst 14:1009-1017.
18. Grunert CM, Schweifer J, Weinberger P, Linert W, Mereiter K, Hilscher G, Mueller M, Wiesinger G, Van Koningsbruggen PJ. 2004. Structure and Physical Properties of [m-Tris(1,4-bis(tetrazol-1-yl) butane-N4,N4')iron(II] Bis(hexafluorophosphate), a New Fe(II) Spin-Crossover Compound with a Three-Dimensional Threefold Interlocked Crystal Lattice. Inorg Chem 43:155-165.
19. Chernyshov D, Hostettler M, Tornroos KW, Burgi H-B. 2003. Ordering phenomena and phase transitions in a spin-crossover compound - Uncovering the nature of the intermediate phase of [Fe(2-pic)3]Cl2 x EtOH. Angew Chem Int Ed 42:3825-3830.
20. Mikami M, Konno M, Saito Y. 1980. The structures of high-spin (298, 150 K) and low-spin (90 K) states and the spin phase-transition mechanism of a spin crossover complex; tris(a-picolylamine)iron(II) chloride-ethanol. Acta Crystallogr Sect B: Struct Crystallogr Cryst Chem B36:275-287.